激光联合康柏西普治疗糖尿病性黄斑水肿的效果

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the effect of laser combined with Conbercept in the treatment of diabetic macular edema(DME).Methods A total of 80 patients with DME admitted to the First Affiliated Hospital of Jiangxi Medical College from March 2019 to March 2020 were selected as the research objects,and divided into control group(40 cases)and experimental group(40 cases)according to random number table method.The control group received laser therapy,and the experimental group was combined with Conbercept therapy.Both groups were followed up for 3 months after treatment.The best corrected visual acuity(BCVA),central macular thickness(CMT)and total macular volume(TMV)of 6 mm were compared between the two groups before treatment,1 week,1 month and 3 months after treatment.Results There was no significant difference in BCVA level between the two groups before treatment(P>0.05).At 1 week,1 month and 3 months after treatment,BCVA levels in both groups were higher than before treatment,and BCVA levels in the experimental group were higher than those in the control group at 1 month and 3 months after treatment,the differences were statistically significant(P<0.05).There was no significant difference in CMT and TMV levels between the two groups before treatment(P>0.05).One week,one month and three months after treatment,the levels of CMT and TMV in both groups were lower than before treatment,and the levels of CMT and TMV in experimental group were lower than those in control group,the differences were statistically significant(P<0.05).Conclusion Laser combined with Conbercept can effectively reduce the level of CMT and TMV in DME patients,improve BCVA,and then improve the level of visual acuity correction,the curative effect is significant,clinical worth promoting.

Key words： Macular edema Diabetic Laser Conbercept Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHENG Lin-lu
	GONG Li-miao
	ZHAN Xin
	LI Xun-yi
	SU Wen-hua
	YIN Qiao
	MAO Yu-jia

Cite this article:

ZHENG Lin-lu,GONG Li-miao,ZHAN Xin, et al. Effect of laser combined with Conbercept in the treatment of diabetic macular edema[J]. 中国当代医药, 2021, 28(27): 158-160-164.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I27/158

[1]	吴小利，廖敏，李涛.玻璃体手术联合曲安奈德治疗对糖尿病性黄斑水肿患者视网膜厚度，视力水平及术后并发症的影响[J].实用医院临床杂志，2020，17（2）：186-188.
[2]	吕旭东，龚兰兰，柴基桥.玻璃体腔内注射曲安奈德联合激光光凝治疗糖尿病性黄斑水肿32 例[J].医药导报，2019，38（1）：62-65.
[3]	刘晓玲，孙祖华.合理使用激光与抗血管内皮生长因子药物，提高糖尿病视网膜病变的治疗水平[J].中华眼底病杂志，2020，36（10）：749-753.
[4]	赵家良.眼科临床指南[M].北京，人民卫生出版社，2006：125-129.
[5]	杨秀芬，韩旭，黄映湘，等.玻璃体腔注射抗VEGF 药物对糖尿病性黄斑水肿患者眼部血流动力学的影响[J].临床和实验医学杂志，2019，2（14）：12-18.
[6]	朱向东，赵伟，孙敏.阈下微脉冲激光与多点扫描激光治疗糖尿病性黄斑水肿的临床疗效[J].中国激光医学杂志，2020，29（1）：12-16.
[7]	刘佳，蒋亚文，倪惟一，等.抗VEGF 类药物与传统激光疗法用于治疗糖尿病性黄斑水肿的药物经济学评价[J].中国药学杂志，2020，3（5）：402-407.
[8]	张建，关小东，方天敏，等.房水细胞因子与糖尿病性黄斑水肿抗VEGF 治疗疗效的相关性[J].中国医药导刊，2019，21（3）：17-22.
[9]	周莉，刘荣，韦晓丹，等.康柏西普眼用注射液联合曲安奈德注射液治疗糖尿病性黄斑水肿的临床研究[J].中国临床药理学杂志，2020，2（13）：1797-1800.
[10]	梁丽银，马萍萍，陈敏瑜，等.康柏西普联合激光治疗糖尿病性黄斑水肿的疗效[J].国际眼科杂志，2019，19（2）：320-322.
[11]	马若璇，冉振龙，张月玲，等.玻璃体内注射康柏西普对糖尿病性黄斑水肿患者黄斑区视网膜血管密度和中心凹无血管区面积的影响[J].眼科新进展，2020，286（4）：70-73.
[12]	梁堂钰，曾惠红，江文良，等.不同抗VEGF 注射液联合视网膜光凝术治疗糖尿病性黄斑水肿的疗效比较[J].解放军预防医学杂志，2019，37（4）：162-163.
[13]	马壮.多点矩阵激光扫描联合康柏西普治疗糖尿病性视网膜病变伴糖尿病黄斑水肿的临床疗效[J].广西医科大学学报，2019，36（8）：1345-1348.
[14]	王建伟，接传红，陶永健.消肿方联合康柏西普对糖尿病黄斑水肿患者视功能的影响[J].国际眼科杂志，2020，20（9）：130-133.
[15]	李帮钰.康柏西普联合激光光凝对糖尿病性黄斑水肿患者视力及黄斑中心厚度的影响[J].实用糖尿病杂志，2020，16（1）：19.
[16]	赵儒意，谭薇.康柏西普联合577 nm 激光治疗糖尿病性黄斑水肿的疗效观察[J].安徽医药，2019，23（11）：2275-2279.
[17]	宋志刚，魏少华.577 nm 激光光凝联合玻璃体内注射康柏西普治疗糖尿病性黄斑水肿的效果观察[J].眼科新进展，2019，39（4）：373-375.